Weight-Loss Drugs Reshape the Supermarket Basket as Retailers Adapt to Smaller Appetites

Britain’s supermarkets are being forced to rethink food ranges, pack sizes and shopper loyalty as the rapid growth of GLP-1 weight-loss drugs begins to reshape what consumers buy.

According to The Observer, retailers are already responding to changing eating habits among users of drugs such as Wegovy and Mounjaro, with demand shifting towards smaller portions, nutrient-dense products and healthier fresh foods.

The trend is expected to accelerate after research from PwC suggested that a newly approved Wegovy tablet could more than double the number of GLP-1 users in the UK, from around three million to seven million people — equivalent to roughly 10 per cent of the population.

For food retailers, the implications are significant. Research from Worldpanel by Numerator, cited by The Observer, found that households using GLP-1 drugs are spending £418 less on groceries than non-users, reducing UK grocery bills by an estimated £780 million.

But this is not simply a story about consumers eating less. It is also about shoppers buying differently.

The Observer reports that GLP-1 users are showing greater interest in fresh foods, including fruit and vegetables, while reducing purchases of some snack and treat categories. At the same time, smaller, portion-controlled products appear to be gaining ground, reflecting the reduced appetites associated with the medication.

The shift is already influencing product development. Marks & Spencer has launched a “Nutrient Dense” range, including salads, snacks and meals packed with fibre, vitamins and minerals. Sainsbury’s, Boots, Morrisons and the Co-op have also introduced similar health-focused lines as retailers look to capture changing demand.

Retail analysts say the commercial challenge for supermarkets is clear. Fresh foods typically deliver lower margins than snack foods, while smaller pack sizes and nutrient-rich ranges require careful pricing and positioning. Retailers therefore face the task of serving a new generation of health-conscious shoppers without eroding profitability.

There are also signs that GLP-1 use could affect supermarket loyalty. The Observer cites Kantar research indicating that 41 per cent of UK users have switched to a new “go-to” supermarket since starting the medication. Tesco and Asda were highlighted as retailers benefiting from perceptions around fresher groceries, smaller product options, healthy lifestyle products and support for customers’ health goals.

The trend could create new opportunities for the fresh produce sector. If GLP-1 users continue to prioritise fruit, vegetables, salads and healthier meal solutions, supermarkets may place even greater emphasis on fresh, convenient and nutritionally appealing produce.

However, the shift also underlines the speed at which consumer behaviour is changing. Weight-loss medication is no longer only a healthcare story. It is becoming a retail story, a food industry story and, increasingly, a fresh produce story.

As GLP-1 use grows in Britain, supermarkets that adapt quickly to smaller appetites, healthier choices and demand for convenient fresh food are likely to be best placed to win the loyalty of this emerging shopper group.